COMMUNIQUÉS West-GlobeNewswire

Transactions in relation to share buyback program
22/07/2019
Announcement no. 43/2019 22 July 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share [...]
Veloxis Revises Outlook for 2019 Based on Strong Performance
22/07/2019
Company Release no. 11/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 22 July 2019 Veloxis Revises Outlook for 2019 Based on Strong Performance Veloxis Pharmaceuticals A/S (OMX: VELO) announced today that it is [...]
ASIT biotech Raises EUR 9.225 Million in a Private Placement of Convertible Notes
22/07/2019
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO [...]
Genmab Announces the Completion of its Initial Public Offering of American Depositary Shares (ADSs) in the United States and Registration of Capital Increase
22/07/2019
Company Announcement Genmab A/S has today completed its initial public offering of American Depositary Shares in the United States and registered a capital increase of 2,850,000 ordinary shares in connection with the [...]
Global Expansion Efforts Begin Yielding Results
22/07/2019
Asia is the first Key Geographic Focal Point NEW HAVEN, Conn., July 22, 2019 (GLOBE NEWSWIRE) -- Specialty Diagnostics company Precipio, Inc . ( NASDAQ: PRPO ), announced today that in conjunction with its global [...]
Bhang CBD Products Now Available in Cannabis Now’s Flagship Beverly Hills Location
22/07/2019
MIAMI, July 22, 2019 (GLOBE NEWSWIRE) -- Bhang Inc. (“Bhang” or the “Company”) (CSE: BHNG) , a trusted cannabis house of brands with an extensive, award-winning portfolio of over 100 cannabis, hemp-derived cannabidiol ( [...]
Innovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Development and Commercialization of Brilacidin in Ulcerative Proctitis/Ulcerative Proctosigmoiditis
22/07/2019
Over $24M in initial and milestone-based payments BEVERLY, Mass., July 22, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to [...]
Naboso™ Technology Announces Partnership with Xero Shoes, Bringing First Barefoot Proprioceptive Sandals to Market
22/07/2019
Leading proprioceptive insole company partners with minimal footwear company to bring patent-pending texture to barefoot sandals NEW YORK, July 22, 2019 (GLOBE NEWSWIRE) -- Naboso™ Technology , creator of the first [...]
Turning Point Therapeutics to Host Second Quarter 2019 Conference Call
22/07/2019
SAN DIEGO, July 22, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, will report second quarter financial [...]
Obalon Schedules Second Quarter 2019 Financial Results Conference Call for July 24, 2019 at 8:30 a.m. Eastern Time
22/07/2019
SAN DIEGO, July 22, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]
Therapeutic Solutions International Reports its NanoStilbene™ Nutraceutical Product Enhances Efficacy of FDA Cleared Cancer Immunotherapy in Animal Model of Cancer
22/07/2019
New Data Supports Development of Patented Formulation of Blueberry Extract Pterostilbene as an Adjuvant to Immuno-Oncology Treatments OCEANSIDE, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics [...]
BioCorRx Announces the Launch of UnCraveRx On-Demand Virtual Fitness, Lifestyle Support and Nutrition App
22/07/2019
ANAHEIM, CA, July 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders [...]
Salarius Pharmaceuticals Enrolls First Patient in a Phase 1 Clinical Study of its Novel Inhibitor Targeting Epigenetics in Patients with Advanced Solid Tumors
22/07/2019
HOUSTON, July 22, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of cancers, today announced it has enrolled the first patient [...]
Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center
22/07/2019
- Compelling responses previously reported with ADP-A2M4 in sarcoma - - Use of low-dose radiation intended to enhance antitumor activity - PHILADELPHIA and OXFORDSHIRE, United Kingdom, July 22, 2019 (GLOBE NEWSWIRE) -- [...]
Results of Single Center Study on Delcath’s PHP Therapy Published in Cancer Imaging
22/07/2019
Retrospective Study by University Hospital of Tubingen Shows Median Overall Survival of 27.4 Months in Patients with Ocular Melanoma Liver Metastases NEW YORK, July 22, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. ( [...]
Salarius Pharmaceuticals Announces Closing of Strategic Merger with Flex Pharma
22/07/2019
To Begin Trading on Nasdaq Capital Market Today Under Ticker Symbol “SLRX” HOUSTON, July 22, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the [...]
Humanigen Secures Exclusive Worldwide License for the Prevention of GvHD through GM-CSF Neutralization from the University of Zurich
22/07/2019
Expands Humanigen’s extensive intellectual property portfolio to include prevention of Graft-versus-Host Disease (GvHD) Strengthens Humanigen’s leadership position and platform in granulocyte macrophage-colony [...]
Alimera Sciences to Report Second Quarter Financial Results on Monday, July 29, 2019 and Provide Corporate Update
22/07/2019
Conference Call to be held Tuesday, July 30, 2019 at 9:00am Eastern Time ATLANTA, July 22, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or the “Company”), a leader in the commercialization [...]
PetMed Express D/B/A 1-800-PetMeds Announces Its First Fiscal Quarter Financial Results and Its Quarterly Dividend of $0.27 Per Share
22/07/2019
DELRAY BEACH, Fla., July 22, 2019 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended June 30, 2019. Net sales for the quarter ended June 30, 2019 were $80 [...]

Pages